Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal Puncture Device received 510(k) clearance from the FDA. Transseptal puncture is designed to enable access to...
Stryker Provides Update After Cyberattack
According to a press release, Stryker Corporation recently “experienced a cybersecurity attack which resulted in a global disruption to Stryker’s (internal, corporate) Microsoft environment.” A cyberterrorist organization, Handala, reportedly claimed responsibility...
Three Knobbe Martens Partners Named Los Angeles Times “Life Sciences Visionaries”
IRVINE, Calif., April 20, 2026 – Knobbe Martens is pleased to share that partners Salima Merani, Ph.D., Jason Jardine, and Kimberly Miller, Ph.D. have been recognized as “Life Sciences Visionaries”...